The Company develops therapeutic drugs designed to treat the underlying causes of degeneration of the brain and the eye as the aging process progresses, initially focusing on Alzheimer's disease.
The best Bull and Bear pitches based on recency and number of recommendations.
Wow, I can't resist the chance to load up after a sell off like this one. Shares will recover with time.
dubious company with even more dubious statistics. High probability of it being a long term loser.
Read the most recent pitches from players about PRAN.DL.
Find the members with the highest scoring picks in PRAN.DL.
See what the Wall Street professionals think, according to their public statements and filings.